Literature DB >> 12087022

Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome.

Jana Vrbíková1, Bela Bendlová, Martin Hill, Markéta Vanková, Karel Vondra, Luboslav Stárka.   

Abstract

OBJECTIVE: To evaluate insulin sensitivity (IS) and beta-cell function (beta F) in lean and obese women with polycystic ovary syndrome (PCOS), either separately or by using a disposition index (DI). RESEARCH DESIGN AND METHODS: A total of 64 women with PCOS and 20 healthy women were examined by anthropometry, oral glucose tolerance tests (OGTTs), and insulin tolerance tests. Statistical analysis used one-way ANOVA, Kruskal-Wallis, and Mann-Whitney U tests, as appropriate.
RESULTS: A significantly higher waist-to-hip ratio (P < 0.0001) was found in both lean and obese women with PCOS. Higher basal blood glucose (P < 0.004) and blood glucose values at 3 h of OGTT (P < 0.008) were found in lean and obese PCOS subjects in comparison with control subjects. Insulin resistance by homeostasis model assessment (P < 0.007) was significantly higher in obese PCOS than in control or lean PCOS subjects. Early-phase insulin secretion (insulinogenic index [Delta I/Delta G(30-0), where I is insulin and G is glucose]; P < 0.0007) was significantly higher in both lean and obese PCOS subjects than in healthy women. All tested combinations of parameters of IS and beta F (DIs) followed a physiological hyperbolic relationship. Significantly lower values of the fasting state-derived DIs were found (all P < 0.05) in obese PCOS subjects. Significantly higher values of all of these indexes derived from nonfasting values were found in lean PCOS as compared with control and obese PCOS subjects (all P < 10(-3)).
CONCLUSIONS: Increased beta F was found even in lean individuals with PCOS. Insulin hypersecretion is thus probably connected to the pathogenesis of PCOS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087022     DOI: 10.2337/diacare.25.7.1217

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Elevated androgen levels induce hyperinsulinemia through increase in Ins1 transcription in pancreatic beta cells in female rats.

Authors:  Jay S Mishra; Amar S More; Sathish Kumar
Journal:  Biol Reprod       Date:  2018-04-01       Impact factor: 4.285

2.  Late pregnancy complications in polycystic ovarian syndrome.

Authors:  I Katsikis; M Kita; A Karkanaki; N Prapas; D Panidis
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

3.  A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility.

Authors:  J E Chavarro; J W Rich-Edwards; B A Rosner; W C Willett
Journal:  Eur J Clin Nutr       Date:  2007-09-19       Impact factor: 4.016

4.  Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.

Authors:  Do Kyeong Song; Young Sun Hong; Yeon-Ah Sung; Hyejin Lee
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 5.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

6.  Developmental programming of polycystic ovary syndrome (PCOS): prenatal androgens establish pancreatic islet α/β cell ratio and subsequent insulin secretion.

Authors:  S Ramaswamy; C Grace; A A Mattei; K Siemienowicz; W Brownlee; J MacCallum; A S McNeilly; W C Duncan; M T Rae
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.